Lynne Williams

Author PubWeight™ 18.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation 2005 2.23
2 Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. JACC Cardiovasc Imaging 2013 1.69
3 Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol 2009 1.67
4 Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish. Blood 2013 1.48
5 Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling. Prog Cardiovasc Dis 2006 1.01
6 Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2012 0.93
7 Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study. Eur J Heart Fail 2011 0.86
8 Profiles of inflammatory cytokines following colorectal surgery: relationship with wound healing and outcome. Wound Repair Regen 2006 0.84
9 Reversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005 0.82
10 Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2013 0.81
11 Evaluation of the effectiveness of two clinical training procedures to elicit yes/no responses from patients with a severe acquired brain injury: a randomized single-subject design. Brain Inj 2003 0.80
12 Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: do we need to stand to be counted. J Am Soc Echocardiogr 2011 0.76
13 Letter by Williams et al regarding article, "Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in medicare patients". Circulation 2011 0.75
14 Predicting the future in hypertrophic cardiomyopathy: from histopathology to flow to function. J Am Soc Echocardiogr 2012 0.75
15 The pathophysiology of heart failure: a tale of two old paradigms revisited. Clin Med 2008 0.75
16 Assessment of right ventricular function. Heart 2008 0.75
17 Effects of bradykinin on venous capacitance in health and treated chronic heart failure. Clin Sci (Lond) 2009 0.75
18 Is it primarily tricuspid regurgitation, constriction or restriction? Heart 2009 0.75
19 Drug-implantable cardioverter-defibrillator interactions. Expert Rev Cardiovasc Ther 2010 0.75
20 More than a midwife? Supervision of extended roles. RCM Midwives 2007 0.75
21 Rapid Pacing-Induced Right Ventricular Dysfunction Is Evident After Balloon-Expandable Transfemoral Aortic Valve Replacement. J Am Coll Cardiol 2017 0.75
22 Cardiac magnetic resonance imaging findings predict major adverse events in apical hypertrophic cardiomyopathy. J Thorac Imaging 2014 0.75
23 Accessing clinical supervision. Nurs Times 2006 0.75
24 Making jobshares work for everyone. Nurs Times 2005 0.75
25 Using the critical incident technique to explore student nurses' perceptions of language awareness. Nurse Educ Today 2007 0.75
26 Device therapy in hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther 2010 0.75